Figure 2From: The role of tumor necrosis factor-alpha in systemic lupus erythematosusGraphic representation of the study plan of the ongoing TRIAL V (Tumor necrosis factor blockade with Remicade In Active Lupus nephritis class V) randomized placebo-controlled clinical trial. More details can be found at [76]. ACE, angiotensin-converting enzyme; WHO, World Health Organization.Back to article page